ABSTRACT This study aimed to establish an accurate and sensitive polymerase chain reaction (PCR) technique for the diagnosis of active human brucellosis in Egypt. We failed to extract Brucella DNA with a commercial kit, but an extraction kit designed in-house using 2 sets of primers [B4/B5 (223 bp) and JPF/JPR (193 bp)] was successful and more economical. The technique showed high sensitivity, specificity and accuracy. The PCR positivity increased significantly with increasing seropositivity titres by the standard tube agglutination test and showed 100% positivity in patients with positive blood cultures. We recommend using PCR as an alternative to culture for diagnosis of brucellosis. 
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Introduction
Brucellosis is an important health problem in Egypt and a confirmed cause of 3% of cases of acute febrile illness [1] . The high frequency of brucellosis and the nonspecific clinical picture emphasizes the importance of laboratory-based diagnosis. Blood culture is the gold standard for microbial diagnosis. However, it may take 2-6 weeks to isolate the organism. Also, prior use of antibiotics may interfere with growth of Brucella spp. Blood cultures require containment level 3 facilities to avoid laboratory-acquired infection, which may limit its use in small and remote health care facilities [2] .
Several serological assays have been developed to diagnose brucellosis. Standard tube agglutination (STA)-the Wright test-is still the most reliable method [3] . Brucellosis can be effectively excluded from diseases having similar clinical features by highly sensitive and specific agglutination tests [4] . However, the presence of antibodies does not always indicate an active case of brucellosis, since humans from endemic areas often show weak serological responses [5] .
In 2003 El-Sherbini et al. carried out a community-based survey in 2 villages in the Nile delta. The seroprevalence of brucellosis among humans was 1.7% and the diagnostic seropositivity level by STA was 1/320 [6] . The endemicity of brucellosis in our country necessitates isolation of the organism for confirmation of high STA positive titres. As for other fastidious pathogens, molecular detection by polymerase chain reaction (PCR) offers an alternative method of diagnosis of brucellosis. There are few studies concerning the use of PCR for diagnosis of brucellosis in humans [7] [8] [9] [10] [11] [12] .
We aimed to establish an accurate and sensitive PCR technique for the diagnosis of active human brucellosis for the first time at the Faculty of Medicine, University of Cairo and the National Research Centre, Cairo. PCR would provide rapid diagnosis of brucellosis, which is important for initiating specific treatment for patients. Furthermore, as brucellosis is a laboratoryacquired infection and may be associated with bioterrorism there are laboratory safety and wider public health implications to establishing such a test.
Methods
Patients
The study was conducted at the University of Cairo and the National Research Centre from July 2005 to September 2006. The sample was 50 patients from Imbaba Fever Hospital and the Tropical Disease Unit, University of Cairo Hospital. The limited number of patients included in the research is related to the budget provided. Consent was taken from patients; no refusal to participate was recorded. The case definition was: clinically suspected brucellosis [13] , positive STA titre ≥ 1:160 and positive blood culture. For each patient we recorded demographic, occupational, clinical and risk factor data.
Laboratory tests
Blood samples were collected aseptically into 2 mL Na-citrate tubes and stored at -20 ºC until analysis.
Standard methods
The serological diagnosis was established by STA (Brucella antigen, Sanofi Diagnosis, Marnes La Coquette, France) using standard methods [3] .
Blood cultures were processed with BACTEC 9050 aerobic blood culture bottles (Becton-Dickinson) and incubated for ٢٠٠9 ،5 ‫العدد‬ ‫عرش،‬ ‫اخلامس‬ ‫املجلد‬ ‫العاملية،‬ ‫الصحة‬ ‫منظمة‬ ‫املتوسط،‬ ‫لرشق‬ ‫الصحية‬ ‫املجلة‬ 21 days. Positive blood culture bottles were subcultured on Brucella blood agar with incubation in 5% CO 2 at 37 ºC for up to 48 hours [2] .
PCR methods
Two methods were used for extraction of DNA from clinical blood samples. The first method was a ready-made extraction kit (BioFlux, Fluxion Biosciences, San Francisco). The second by an extraction technique designed in-house by modification of the method described by Miller et al. [14] , as follows.
• Blood was suspended in 0.5 mL of erythrocyte lysis solution (320 mM saccharose, 5 mM Mg 2 Cl, 1% triton X-100 and 10 mM tris HCl (pH 7.5), mixed, and centrifuged at 15 000 g for 2 min before discarding the supernatant. The leukocyte pellet was washed with 1 mL of sterile Milli-Q® water. For elimination of any remains of the haeme compound, 100 μL of an H 2 O 2 (30% wt/wt) solution was added to the pellet and incubated for 2-5 min at room temperature. The H 2 O 2 was removed with the tip of the pipette.
• Then 400 μL of nucleic lysis buffer (60 mM NH 4 Cl and 24 mM Na 2 EDTA (pH 8.0) containing proteinase K (10 mg/ mL) and sodium dodecyl sulfate (10%) was added to the pellet, mixed and incubated for 30 min at 55 ºC or overnight at 37 ºC with slow shaking. The samples were cooled at room temperature and 100 μL of ammonium acetate (7.5 M) was added to each tube. The tubes were shaken for 30 s, followed by centrifugation at 15 000 g for 10 min. The supernatant containing total DNA was transferred to a fresh tube. Two volumes of absolute alcohol were added and the tubes were inverted several times until the DNA was precipitated.
• DNA was recovered by centrifuging the samples at 15 000 g for 10 min, and the pellets were rinsed with 1 mL of 70% ethanol, dried and suspended in 40 μL of sterile Milli-Q® water. The concentration and purity of the DNA were then determined spectrophotometrically by readings of A260 and A280. DNA amplification was done by 2 different PCR sets of primers: B4/B5 (223 bp) and JPF/JPR (193 bp). Most cases were carried out in duplicate.
• Primers B4 (5'-TCGGTTGCCAATAT-CAA-3') and B5 (5'-CGCGCTTGCCTT-TCAGGTCTG-3') were used to amplify a target sequence of 223 bp present on a gene encoding a 31 kDa B. abortus antigen. This sequence has been shown to be common to all Brucella biovars. • Primers JPF (5'-GCGCTCAGGCTG-CCGACGCAA-3') and JPR (5'-ACC-AGCCATTGCGGTCGGTAA-3') were used to amplify a target sequence of 193 bp. Isolated DNA was amplified as described above, except for the concentrations of MgCl2 (3 mM) and primers (JPF/JPR, 300 nM each) [15] . This PCR consisted of an initial 4 min incubation step at 94 ºC, followed by 35 cycles with denaturation at 94 ºC, annealing at 60 ºC and extension at 72 ºC (each for 1 min) and a final 5 min extension step at 72 ºC. For quality control the positive control was DNA extracted from Brucella colonies provided courtesy of the Naval American Medical Research Unit No. 3. The DNA was extracted from Brucella spp. colonies isolated from 2 different patients who suffered from brucellosis and whose laboratory results were positive by serology and blood culture. For the negative control all reagents were added except Brucella DNA.
The sample was considered positive when DNA with a molecular weight expected for the amplified product was observed after electrophoresis in 2% agarose with fluorescence in the presence of ethidium bromide (2 μg/mL). PCR amplification products were detected through visualization of bands under ultraviolet light.
Statistical analysis
All tabulated data were interpreted and analysed using SPSS, version 13. Independent t-test and chi-squared tests were used to detect significant differences (P < 0.05).
Results
Clinical data
The median age of the patients was 32 years (range 13-55 years); 36 (72%) were males. Of the 50 patients, 23 had a risk factor for brucellosis; 21 (42%) had contact with animals, either occupational [9 cases (18%) were farmers and butchers] or keeping animals near where they lived [12 (24%) cases]; 2 patients (4%) had a history of consuming unpasteurized milk. The exposure to risk factors was highly significant for brucellosis (P = 0.008).
Serology
Of the 50 patients, 6 (12%) had an STA titre of 1/160, 12 (24%) had 1/320, 16 (32%) had 1/640 and 16 (32%) had 1/1280 (Table 1) .
Blood cultures
Brucella spp. were isolated in blood cultures from 15 patients who had not received 
PCR results
Using the ready-made extraction kits all samples gave negative results by the 2 protocols. Repetition of extraction using the inhouse extraction technique was successful and PCR was positive in 35 samples ( Figure  1 ). PCR was positive for all patients with positive blood cultures.
Evaluation of the technique
PCR positivity increased significantly with increasing seropositivity (P = 0.001). In cases with low STA positive titres 1/160, all PCR results were negative, out of 12 cases with titre 1/320, 7 cases were negative and out of 16 cases with titre 1/640, 2 cases were negative, while in the 16 cases with high titre 1/1280, all PCR results were positive (Table 1) . Using positive blood culture as a gold standard [16] , our PCR technique showed a sensitivity of 100%. Using STA titre > 1/160 as a gold standard [7] the sensitivity was 79% and the specificity was 100% (Table 2) .
Discussion
In our study, the median age of patients was 32 years (range 13-55) and 72% were males.
In a study that implemented laboratorybased surveillance in hospitals through Egypt, patients had a median age of 30 years (range 4-90) and 65% were males [1]. In Banha, Egypt, the age range was 23-56 years [16] , while in Jordan the median age was 46 years (range 6-86) [5] and in Italy the median age was 42 years (range 16-47) [17] . We found that the risk factors for brucellosis were occupational exposure (farmers and butchers), drinking unpasteurized milk and history of contact with animals (P = 0.008). These data are consistent with Afifi et al.'s study on brucellosis in Egypt [1]. Although most researchers have used commercial kits for extraction of Brucella DNA [10, 12] we failed to extract DNA using a commercial kit and this technique was discontinued. We used an in-house extraction method modified from the methods of Miller [14] , which was successful and [18, 19] . This high sensitivity in culturepositive cases suggests that PCR may replace blood culture as the gold standard for acute brucellosis.
The sensitivity of PCR using titre > 1/160 as a gold standard was 79% and the specificity was 100%. Others who have tried to establish a PCR technique for diagnosis of human brucellosis found the sensitivity was 50% and the specificity 60% [10] . The existence of false negatives could be due to the presence of polymerase inhibitors. Many substances have been suggested as amplification inhibitors, including haemoglobin, urine, heparin, phenol and sodium dodecyl sulfate. In our study we used H 2 O 2 to avoid this effect. Test sensitivity is also influenced by DNA extraction and detection procedures [10] . Other hypotheses to account for false-negative PCR results are the presence of a number of organisms below the detection limit and the degradation of target DNA in the samples [20] .
The PCR positivity in our study increased significantly with increasing seropositivity. This can to some extent be explained by false positive serology results at titre 1/160 due to the endemicity of brucellosis in Egypt. This agrees with El-Sherbini et al. in Egypt who recommended increasing the seropositivity level of STA to 1/320 [6] , while another study from Egypt used a positive agglutination titre > 1/160 as seropositive for brucellosis [16] . A study from Saudi Arabia showed that PCR was positive in 80% of symptomatic cases with titre 1/160 and the author recommended that titres > 1/160 should be reported as positive [21] . A study from Jordan also considered 1/160 as positive for serodiagnosis [5] . So we recommend performing a larger study in all governorates of Egypt to establish a titre for serodiagnosis of brucellosis in Egypt.
In conclusion, we have established an accurate and sensitive PCR technique for the first time in 2 important academic centres in Egypt: the Faculty of Medicine, University of Cairo and the National Research Centre. Our PCR technique proved to be both sensitive and specific. We recommend using PCR as an alternative to blood culture for diagnosis of acute brucellosis. Further studies are required to compare different techniques. We also recommend performance of a largescale study to test this PCR technique for screening for brucellosis in Egypt.
